Pertussis Vaccine Market Size Projected To Reach $6.62 Billion By 2034 With A Cagr Of 3.7%

The Pertussis Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Pertussis Vaccine Market?
In recent times, the market size for the pertussis vaccine has been experiencing consistent growth. Projections show a rise from $5.5 billion in 2024 to $5.72 billion in 2025, which represents a compound annual growth rate (CAGR) of 4.1%. Factors such as the prevalence of the disease, immunization drives, pediatric inoculations, and regulatory approvals have contributed to this growth in the historical period.

In the forthcoming years, the pertussis vaccine market size is projected to experience uniform growth and it's expected to reach $6.62 billion in 2029 with a compound annual growth rate (CAGR) of 3.7%. The predicted growth can be linked to factors like booster vaccination, maternal immunization, immunization for healthcare workers and global health initiatives during the forecast period. Key trends that will be seen during the forecast period encompass personalized immunization schedules, combination vaccines, vaccine equity initiatives, and the use of digital health for immunization.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

What Are the Different Pertussis Vaccine Market Segments?
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What Are the Primary Drivers Shaping the Pertussis Vaccine Market?
The expansion of the pertussis vaccine market is spurred by the growing childbirth rates. Pertussis vaccine is predominantly used for children as it safeguards them from fatal illnesses including whooping cough. Childbirth signifies the process of delivering a baby, marking the commencement of life outside the womb. It is the culmination of pregnancy, wherein the baby grows inside the mother's uterus. For instance, in 2023 January, the US recorded a 1% increase in childbirth, amounting to 3,664,292, according to a report by the US-based public health organization, the Centers for Disease Control and Prevention. Consequently, the escalation in childbirth rates bolsters the pertussis vaccine market growth. The pertussis Vaccine Market Driver 1 includes an increased geriatric population that fuels the growth of the pertussis vaccine market. The demographic group aged 65 and above is referred to as the geriatric population. The surge in geriatric population majorly contributes to the pertussis vaccine market growth, as more people are living longer, leading to a spike in demand for the pertussis vaccine to shield older adults from serious diseases. As per the World Health Organization, an intergovernmental health organization based in Switzerland, in October 2022, the worldwide population of individuals aged 60 years and above is expected to double by 2050, reaching 2.1 billion. Furthermore, the population of people aged 80 years or older is projected to triple from 2020 to 2050, amounting to 426 million. Hence, the rise in geriatric population propels the pertussis vaccine market growth.

Which Companies Are Leading in the Pertussis Vaccine Market?
Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

What Are the Major Trends Shaping the Pertussis Vaccine Market?
Key players in the pertussis vaccine market are concentrating on the development of novel drugs and acquiring necessary governmental approvals in order to maintain their industry standing. For instance, in October 2022, GSK plc., a pharmaceutical and biotech firm based in the UK, publicized the approval of BOOSTRIX by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a Tdap vaccine, consisting of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed. Its purpose is to prevent pertussis, otherwise known as whooping cough, in newborn babies, by administering it once into the upper arm muscle during pregnancy. It has been found to be safe and effective for both pregnant women and their infants, successfully preventing pertussis, even in its more severe manifestations.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

What Are the Top Revenue-Generating Geographies in the Pertussis Vaccine Market?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pertussis Vaccine Market?
2. What is the CAGR expected in the Pertussis Vaccine Market?
3. What Are the Key Innovations Transforming the Pertussis Vaccine Industry?
4. Which Region Is Leading the Pertussis Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.